Maravai Lifesciences Holdings (MRVI) Net Income towards Common Stockholders Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) Net Income towards Common Stockholders Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -58.11% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 104.24% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -290.15% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -129.68% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 743.11 Mn | 734.71 Mn | 33.70 Mn | 87.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.93% |
| Dec 31, 2025 | -36.79% |
| Sep 30, 2025 | 73.87% |
| Jun 30, 2025 | -279.14% |
| Mar 31, 2025 | -133.04% |
| Dec 31, 2024 | 58.11% |
| Sep 30, 2024 | -1,041.93% |
| Jun 30, 2024 | -54.23% |
| Mar 31, 2024 | -1,582.49% |
| Dec 31, 2023 | -225.80% |
| Sep 30, 2023 | -115.15% |
| Jun 30, 2023 | -107.62% |
| Mar 31, 2023 | -100.92% |
| Dec 31, 2022 | -31.22% |
| Sep 30, 2022 | -24.61% |
| Jun 30, 2022 | 16.52% |
| Mar 31, 2022 | 94.61% |
| Dec 31, 2021 | 778.32% |
| Sep 30, 2021 | 238.72% |
| Jun 30, 2021 | 9,227.12% |